Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | 2026-06-17 | Ogden Christopher | Chief Financial Officer | Sale | 1,624 | $3.05 | $5K | 295.3K | View | |
| 2026-03-17 | 2026-03-19 | Chu Yu-Waye | Chief Medical Officer | Sale | 21.3K | $6.42 | $137K | 189.4K | View | |
| 2026-03-17 | 2026-03-19 | McCarthy Sean A. | Director & CEO | Sale | 119.0K | $6.42 | $764K | 1.08M | View | |
| 2026-03-17 | 2026-03-19 | BELVIN MARCIA | SVP, Chief Scientific Officer | Sale | 31.5K | $6.42 | $202K | 300.8K | View | |
| 2026-03-17 | 2026-03-19 | Ogden Christopher | Chief Financial Officer | Sale | 19.3K | $6.42 | $124K | 296.9K | View |
Informational purposes only, not investment advice.
tormere.com/research/CTMX · generated 2026-11-07
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-06-15 | Ogden Christopher | S | 1,624 | $4,953.2 |
| 2026-03-17 | Chu Yu-Waye | S | 21,279 | $136,675.02 |
| 2026-03-17 | McCarthy Sean A. | S | 118,969 | $764,137.89 |
| 2026-03-17 | BELVIN MARCIA | S | 31,492 | $202,273.12 |
| 2026-03-17 | Ogden Christopher | S | 19,323 | $124,111.63 |
Tormere — informational purposes only, not investment advice.